Related by context. All words. (Click for frequent words.) 69 Ercole Biotech 68 Paladin Labs 67 Initiates Clinical 67 Zeneus 66 Initiates Clinical Trial 66 Neurimmune 66 IV Busulfex 66 Vernalis plc 66 Locus Pharmaceuticals 65 Prometic 65 Initiates Enrollment 65 Arno Therapeutics 65 Chronogen 65 Fresenius Biotech 65 Prism Pharmaceuticals 65 Viventia Biotech 65 Viventia Biotech Inc. 65 Ambrilia Biopharma 65 H3 Pharma 65 Syntonix 65 Initiate Clinical Trial 65 Xillix 65 Alnara Pharmaceuticals 64 Argenta Discovery 64 Submits Response 64 Vaccinex 64 SOLVAY PHARMACEUTICALS 64 PF # [002] 64 Valeant Pharma 64 Milestone Payment 64 Therapeutic Competitors Report 64 ChondroGene 64 Taligen Therapeutics 64 Receive Milestone Payment 64 Revotar 64 Receives Milestone Payment 64 Galenea 64 Transition Therapeutics 64 FoldRx Pharmaceuticals Inc. 64 GenWay Biotech 64 Idera Pharmaceuticals 64 ViroChem Pharma Inc. 64 immunotherapy treatments 64 Bellus Health 64 Oncobionic 64 MacroMed 64 Teikoku Pharma USA 64 Marillion Pharmaceuticals 64 SinuNase ™ 64 Salmedix 64 AEterna 64 iCeutica 64 Raven Biotechnologies 64 Immunotherapeutic 63 Capsulution 63 KaloBios 63 Genome Therapeutics 63 Shire BioChem Inc. 63 Lorus Therapeutics 63 WILEX 63 Pancreate 63 JCR Pharmaceuticals 63 BioDelivery 63 DP VPA 63 PDE# inhibitors 63 Supernus Pharmaceuticals 63 Syntonix Pharmaceuticals 63 Oxford Genome Sciences 63 CellGate 63 Cyclacel Pharmaceuticals 63 Fovea Pharmaceuticals 63 Apitope 63 Milestone Payment From 63 Potelligent Technology 63 OncoMethylome Sciences 63 InNexus Biotechnology 63 AMEX REX 63 Zentaris 63 Spiegelmer 63 Antibody Discovery 63 Viacell 63 CureTech 63 Alexion Pharma 63 Othera Pharmaceuticals Inc. 63 Akela Pharma Inc. 63 Onko Sure TM 63 BiolineRX 63 MedGenesis 63 Nippon Shinyaku 63 GeneOhm Sciences 63 ImmunoVaccine Technologies 63 Chemokine 63 Astex Therapeutics 63 Migenix 63 BioGeneriX 63 Creabilis Therapeutics 63 Kiadis 63 Aegera 63 Martin Nicklasson CEO 63 Auxilium Pharma 63 Oasmia 63 Onconase 63 DermTech International 63 Catalyst Biosciences 63 Nitec 63 Microbix Biosystems 63 Seikagaku 63 Evolva 63 Cumulase 63 Ception Therapeutics 63 CureDM 63 Quark Biotech 63 Gendux AB 63 Transcept Pharmaceuticals 63 Neurobiological Technologies 62 Dexo 62 Selvita 62 Files IND 62 TKPHF 62 Pierre Fabre SA 62 Initiates Phase II 62 Pernix Therapeutics 62 Anthony Giovinazzo 62 Akela Pharma 62 Wellstat 62 Forma Therapeutics 62 NASDAQ PPDI 62 Innate Pharma 62 Azur Pharma 62 BioSante Pharmaceuticals Announces 62 Gentamicin Surgical Implant 62 Submits NDA 62 Revance 62 Janssen Pharmaceutica NV 62 Quark Pharmaceuticals 62 TapImmune 62 BTG plc 62 rxRNA 62 Xenon Pharmaceuticals 62 Celmed 62 Neuromed Pharmaceuticals Ltd. 62 Insert Therapeutics 62 Pathway Diagnostics 62 MultiCell Technologies 62 Bellicum 62 NeuroMedix 62 Peptimmune 62 Sigma Tau Pharmaceuticals 62 Bioservices 62 Biotest AG 62 Cenomed 62 BioDelivery Sciences 62 SansRosa 62 Draxis Health 62 Isis Pharma 62 Viralytics 62 ProMetic BioSciences 62 CyDex Pharmaceuticals 62 Napo Pharmaceuticals 62 Cx# [002] 62 FluoroPharma 62 Licenses Novel 62 Alantos 62 Reports Preclinical Data 62 Genotyping Test 62 Zenyaku Kogyo 62 elbion 62 Neurobiological Technologies Inc. 62 neurology immunology 62 Sygnis 62 Caprion 62 Entocort 62 Myrexis Inc. 62 Nasdaq CRXL 62 Sylvie Gregoire President 62 ARIUS Research 62 Tobira Therapeutics 62 RDYN 62 Tibotec BVBA 62 Nasdaq CGEN 62 ERYtech 62 Vicuron Pharmaceuticals 62 Orqis Medical 62 Inflazyme 62 Receives Orphan Drug Designation 62 Genpharm 62 NASDAQ VRUS 62 Procyon Biopharma 62 RxKinetix 62 AVEO Pharmaceuticals 62 Targeted Chemotherapy 62 Saegis Pharmaceuticals 62 Alnylam Nasdaq ALNY 62 Ophthotech 62 Aegera Therapeutics 62 Scynexis 62 MBX TSX 62 Cara Therapeutics 62 Seikagaku Corporation 62 Brussels THR 62 Begins Dosing 62 Agios Pharmaceuticals 62 OPi 61 Piramed 61 ZBx 61 Gets FDA Clearance 61 Penwest Pharma 61 gets USFDA nod 61 Olerup SSP 61 Scancell 61 ERYtech Pharma 61 CHDI Foundation 61 NYSE Amex YMI 61 Announce License Agreement 61 Cellzome 61 Xcytrin R 61 Vion Pharmaceuticals 61 QuantRx Biomedical Corporation 61 LEAD Therapeutics 61 Avila Therapeutics 61 InfaCare Pharmaceutical Corporation 61 Alnylam Pharma 61 Transkaryotic Therapies TKTX 61 Receives Approvable Letter 61 Therapeutic Competitors Companies 61 outlicensed 61 Fabry Disease 61 Acrux Limited 61 Adamis Pharmaceuticals 61 Enhanze 61 Dynogen 61 Amarantus 61 Adenosine Therapeutics 61 Albugon 61 Ecallantide 61 EKR Therapeutics 61 Genaco Biomedical Products 61 Veridex LLC 61 Debiopharm SA 61 Akebia Therapeutics 61 KAHR Medical 61 YM AIM YMBA 61 mtm laboratories 61 Calixa Therapeutics 61 commercialize pimavanserin 61 Picchio Pharma Inc. 61 Biophage 61 Prometheus Laboratories 61 Biomarker Study 61 Procognia 61 DeveloGen 61 Paladin Labs Inc. 61 Synerx Pharma 61 Meets Primary Endpoint 61 HuMax TAC 61 OncoTherapy Science 61 X Ceptor Therapeutics 61 Senexis 61 Cytokine PharmaSciences 61 Intellect Neurosciences 61 Angiochem 61 Novosom 61 Dynepo TM 61 Aspreva Pharmaceuticals Corporation 61 KuDOS 61 prostone 61 Davanat 61 immatics 61 GIPET 61 Oncolys 61 Myocet 61 ViroChem 61 Chemokine Therapeutics 61 romazarit 61 glucokinase activator 61 Ipsen SA 61 OTCBB PWRM.OB 61 IMPACS R 61 Celmed BioSciences 61 Biotrin 61 NIR Diagnostics 61 Actelion Pharmaceuticals Ltd 61 Synosia Therapeutics 61 ESBATech AG 61 Initiates Dosing 61 ZaBeCor 61 Biolipox 61 Commercialize Novel 61 Lung Rx 61 HyACT 61 Sunshine Biopharma 61 NASDAQ FLML 61 Enterix 61 Emisphere Technologies 61 NYSE Amex AEN 61 ImaginAb 61 Metrika 61 TRACON Pharmaceuticals 61 Affinium Pharmaceuticals 61 Bovie Medical 61 Genetic Therapy 61 ProtAffin 61 Meritage Pharma 61 Santaris 61 Glassia 61 SYGNIS 61 Chroma Therapeutics 61 HalcyGen 61 Conatus Pharmaceuticals 61 Millenia Hope Biopharma 61 AB OMXS BINV 61 Galderma SA 61 Kyowa Kirin 61 Campto 61 Zygogen 61 Chiral Quest 61 fipamezole 61 Sanochemia 61 Inc. OTCBB ALRX 61 Tego Biosciences 61 NPS Pharma 61 ZARS Pharma 61 Alligator Bioscience AB 61 ZEVALIN ® 61 Aggrastat 61 Allon Therapeutics 61 NRGN 61 Portola Pharmaceuticals 61 Velcade bortezomib 61 AMEX RGN 61 TransPharma 61 AclarusDx 61 Celator 61 Announces Poster Presentations 61 Receptos 61 Aposense 61 Completes Patient Enrollment 61 StromaCel Inc. 61 Miracor 61 YM Biosciences 61 Cenix BioScience 61 Therinject 61 Ascend Therapeutics 61 PsychoGenics 60 OTCBB PYTO 60 BioAxone 60 Milestone Payments 60 Dermylex TM 60 BioSyent Pharma 60 thalidomide Thalomid 60 Expression Genetics 60 Medistem Laboratories 60 Melior Discovery 60 Janssen Alzheimer Immunotherapy 60 Lupin Pharmaceuticals 60 NOXXON 60 Zenapax 60 BioGeneriX AG 60 Bertek Pharmaceuticals 60 Sanvar 60 Abbott Molecular 60 Vysis 60 Response Biomedical 60 Prima BioMed 60 Aflibercept 60 Systemic Delivery 60 Ascenta Therapeutics 60 AviaraDx 60 Presents Preclinical 60 NASDAQ ALNY 60 NeuroSolutions 60 Anavex #-# 60 EOS NASDAQ MELA 60 ExonHit 60 Xenazine ® 60 Ore Pharmaceuticals 60 ProFibrix 60 Initiates Phase III 60 Vegenics 60 PGL# 60 Progenics Pharmaceuticals 60 Stem Cell Innovations 60 EnVivo 60 Immunex Corporation 60 GeneOhm 60 NLTX 60 Tibotec Pharmaceuticals Ltd. 60 Begins Clinical Trial 60 LymphoStat B TM 60 Gemin X Pharmaceuticals 60 Martin Nicklasson 60 Psivida 60 Thallion Pharmaceuticals 60 MBRX 60 Initiates Phase 2b 60 therapeutic monoclonal antibodies 60 Sirion Therapeutics 60 HaptoGuard 60 Tikvah Therapeutics 60 aerosolized AAT 60 KAI Pharmaceuticals 60 Quotient Bioresearch 60 Regeneron Pharma 60 Santhera Pharmaceuticals 60 NASDAQ AEZS 60 dSLIM 60 Adeona Pharmaceuticals 60 iCardiac Technologies 60 Serentis 60 biosurgical 60 Personalized Immunotherapy 60 Apokyn 60 Successfully Completes Phase 60 Caris MPI 60 miRagen Therapeutics 60 TransTech Pharma 60 adenosine A2A 60 Virium 60 Verus Pharmaceuticals 60 Aerovance 60 EHT Dx# 60 hereditary emphysema 60 Monoclonal antibody 60 PAION AG ISIN 60 including eniluracil ADH 60 BioTie 60 Genvec 60 Phytomedics Inc. 60 Ibis Biosciences 60 FDA Approvals 60 Procyon Biopharma Inc. 60 Phoqus 60 CysDisplay 60 RTP #i 60 NormOxys 60 Ikaria Holdings Inc. 60 Prodarsan R 60 Taiho Pharmaceutical 60 Ergomed 60 HuMax 60 Adherex Technologies 60 Protalex Inc. 60 therapeutic monoclonal antibody 60 Teijin Pharma 60 Pegloticase 60 Begin Clinical Trials 60 Adventrx Pharmaceuticals 60 EpiTherapeutics 60 Sontra Medical Corporation 60 CeNeRx BioPharma 60 Submits IND 60 Igeneon 60 InvaGen 60 Anidulafungin 60 Gemin X Biotechnologies 60 Nipent R 60 Fournier Pharma 60 SagaX 60 NorDiag ASA 60 Alantos Pharmaceuticals 60 FOR FURTHER INFORMATION ABOUT 60 Jaiva Technologies 60 Anticancer Agent 60 Genaera Corporation 60 AQUA ® 60 Inex Pharmaceuticals 60 Inspire Pharma 60 Xenoport Inc. 60 preanalytical sample preparation 60 License Option Agreement 60 Jubilant Biosys 60 MDS Sciex 60 Earns Milestone Payment 60 PDE4 inhibitor 60 Ambion Diagnostics 60 biologic therapeutics 60 Liprotamase 60 Euroscreen 60 Embolic Protection 60 BRILINTA 60 Sunesis Pharmaceuticals 60 Pipex Pharmaceuticals 60 RECOTHROM R 60 VentiRx Pharmaceuticals 60 OncoGenex Technologies 60 Cannasat 60 Loramyc ™ 60 Cornerstone BioPharma 60 Alza Corporation 60 SoluBest 60 anti CD3 monoclonal 60 Theramex 60 Alnylam ALNY 60 bioFILM PA TM 60 Vincent Mutel CEO 60 t2cure GmbH 60 Spiegelmer ® 60 ImmunoCellular Therapeutics 60 Cellmid 60 Gelclair 60 Ceflatonin R 60 TELINTRA R 60 Urokinase 60 Aviptadil 60 Cobra Biomanufacturing 60 Almac Diagnostics 60 Synergy Pharmaceuticals 60 CIMA LABS 60 TSXV BIO 60 PNT# 60 EHT AGN 60 Biomarin 60 Viron Therapeutics 60 Announces Tentative Approval 60 initiated Phase Ib 60 NASDAQ ENMD 60 Sopherion 60 Neurobionix 60 Enters Into Collaboration 60 Initiates Clinical Trials 60 Optimer Pharma 60 Acuity Pharmaceuticals 60 Hoyoung Huh 60 FineTech 60 Lantibio 60 molecular diagnostic assay 60 Argatroban 60 Phase 2a Trial 60 Medgenics 60 QuantRx ® 60 Endotis 60 Oxis International 60 Anti Infective 60 bioLytical 60 RhuDex R 60 Novartis NVS Snapshot Report 60 Drug Candidate 60 Restructures Operations 60 Nasdaq ACHN 60 Digna Biotech 60 Tesmilifene 60 Syntaxin 60 OTCBB CVBT 60 IG HCR ;) CO 60 GTC NASDAQ GTCB 60 ActivX 59 Axentis Pharma 59 novel therapeutic antibodies 59 Gamida 59 PharmaNova 59 Enzyme Replacement Therapy 59 Validus Pharmaceuticals 59 Nasdaq PARD biopharmaceutical 59 Ethypharm SA 59 Medicis Pharmaceutical Corp 59 LSE ASM 59 targeted radiotherapeutic 59 Javelin Pharmaceuticals 59 Granted Orphan Drug 59 Sirius Genomics 59 DOV Pharmaceutical 59 Virdante 59 Investigational Treatment 59 Senesco Technologies 59 OTCBB NRGX 59 ROSG 59 Gamunex C 59 EMD Biosciences Inc. 59 beta 1a 59 VisEn Medical 59 Pennsaid R 59 Seattle Genetics SGEN 59 Rapinyl 59 KAI Pharmaceuticals Inc. 59 Æterna Zentaris 59 Tranzyme Pharma 59 Suprax R 59 Nautilus Biotech 59 BioTherapeutics 59 TaiGen 59 ANIK 59 ACADIA Pharmaceuticals 59 NTII 59 Vantas 59 SR Pharma 59 Curacyte 59 Angioblast 59 Vitro Diagnostic IVD 59 ValiRx 59 Valera Pharmaceuticals 59 Shanghai Medicilon 59 Insmed Incorporated NASDAQ INSM 59 Miikana Therapeutics 59 Circ Pharma 59 NuroPro ® 59 Biosign Technologies Inc. 59 Celera CRA 59 Morphosys 59 VitiGam 59 Gruenenthal 59 Frova ® 59 Biotica 59 Protalix Biotherapeutics 59 Novel Therapeutic 59 Onalta TM 59 Xytis 59 Intendis 59 Announcement acc 59 Axcan Pharma 59 Abstral ® 59 Theraputics 59 LUCASSIN 59 Diatos 59 Psynova 59 Amira Pharmaceuticals 59 IncellDx 59 Janssen AI 59 Maribavir 59 VentiRx 59 Combunox 59 NorDiag 59 Nasdaq DYAX 59 FivePrime Therapeutics 59 Optimata 59 Idun Pharmaceuticals 59 Trobalt 59 Bioheart Inc. 59 Juvantia 59 developer Antisoma plc 59 OGeS 59 Proprietary Products 59 Exploit collaboration 59 Inflazyme Pharmaceuticals 59 Myocardial Perfusion Imaging 59 Tragara Pharmaceuticals Inc. 59 Orapred ODT 59 CardioVascular BioTherapeutics 59 Septin 9 59 MAXY VII 59 plasmid DNA pDNA 59 Zenpep 59 ExonHit Therapeutics SA 59 ophthalmics 59 Sanochemia Pharmazeutika AG 59 InVasc 59 DepoCyt 59 Dr. Aiping Young 59 OXBT 59 CNS Disorders 59 Damian Marron 59 HepeX B 59 exclusive sublicense 59 OTCBB PYTO FWB ET6 59 CYTC 59 & LSE GLPG 59 Receives Orphan Drug 59 Presents Preclinical Data 59 Inc Therapeutic Competitors 59 Spectral Diagnostics Inc. 59 Supernus Pharmaceuticals Inc. 59 Caprion Proteomics 59 enGene 59 Neuroptix 59 SymBio 59 Shire plc SHPGY 59 Files Investigational 59 Xanthus Pharmaceuticals Inc. 59 Nancy Wysenski 59 Atugen 59 Orphan Status 59 Mpex 59 APT Pharmaceuticals 59 Genospectra 59 Montigen 59 Hybridon 59 TSX PLB 59 Cordis Endovascular 59 Aileron Therapeutics 59 NASDAQ CRTX 59 Osmetech Molecular Diagnostics 59 Amplimmune 59 Announce Collaboration Agreement 59 BioAxone Therapeutic 59 Synairgen 59 Cardioxyl Pharmaceuticals 59 Meda STO MEDAA 59 NASDAQ CRXL 59 NASDAQ CLSN 59 mSEPT9 biomarker 59 REGiMMUNE 59 Alethia Biotherapeutics 59 IntelliPharmaCeutics 59 NASDAQ EMIS 59 Romark Laboratories 59 Ascentage Pharma 59 NASDAQ DIGE 59 Evoltra ® 59 immunodiagnostic 59 Drug Shows Promise 59 outlicensing 59 arGentis 59 Decision Biomarkers 59 segment Biotest 59 treat gastrointestinal disorders 59 Regulus Therapeutics 59 Addrenex 59 Diatos SA 59 Naglazyme R 59 DepoDur 59 Maxy G# 59 Santhera 59 NASDAQ INFI 59 FDA Approvable Letter 59 Novel Antibody 59 FORMA Therapeutics 59 CRYO 59 Archemix Corp. 59 AION Diagnostics 59 thetreatment 59 MOVIPREP R 59 Covalon Technologies 59 Cellpep 59 Synt em 59 Integra Lifesciences 59 Ortho Clinical 59 ZLB Behring 59 QSV Biologics 59 TissueInformatics 59 photodisinfection 59 Lipoxen 59 Oxford BioTherapeutics 59 GammaCan 59 iCardiac 59 ATG Fresenius S 59 Zentaris GmbH 59 TAXOL 59 SynX 59 Equetro 59 Adnectin 59 Akorn Inc 59 Clinigene 59 Presents Positive 59 Lightlake Therapeutics 59 TLR9 agonist 59 personalized cellular immunotherapy 59 ViRexx Medical Corp. 59 Antisense Pharma GmbH 59 ThromboGenics NV 59 UCB Pharma SA 59 Anchor Therapeutics 59 Sanvar R 59 Neurobiological 59 Nitec Pharma 59 Fludara ® 59 Factor VIIa 59 VitiGam TM 59 Cerenis Therapeutics 59 defensin mimetic antibiotic 59 subcutaneous immunoglobulin 59 Curidium 59 Affitech AS 59 Avidex 59 Tokai Pharmaceuticals 59 RhuDex ® 59 Vernakalant 59 Inc. NASDAQ ICGN 59 Keryx Biopharma 59 Quark Biotech Inc. 59 Fluconazole 59 MOGN 59 BioMedica 59 RNA antagonists 59 Clovis Oncology 59 proprietary capillary aerosolization 59 MDxHealth 59 MKC# MKC# PP 59 Urodynamix 59 Zeneus Holdings 59 Spinal Concepts 59 Angiocept 59 TSX IZP 59 markets HP Acthar 59 BIOCEUTICALS 59 Biovail Laboratories International 59 AclarusDx ™ 59 PRNewswire FirstCall YM BioSciences 59 Ethypharm 59 BioProgress plc 59 Enzon Pharmaceuticals 59 Xerecept 59 TTHI 59 CellExSys 59 Crop BioScience 59 ZARS 59 CCR9 antagonist 59 GW# [003] 59 Astex Therapeutics Limited 59 Fumapharm 59 Accentia Biopharmaceuticals 59 Thrombin 59 VASTox 59 Corautus Genetics 59 Ondine Biopharma 59 BioNumerik 59 Nuvo Research 59 CancerVax Corporation 58 Inc. AMEX LIV 58 PSDV 58 FOLOTYN ® 58 Elixir Pharmaceuticals 58 Collaborators Publish 58 LGND 58 Metabasis Therapeutics 58 Oxxon 58 Nycomed GmbH 58 THALOMID 58 RGDX 58 Interface Biologics 58 X Ceptor 58 Barrier Therapeutics Inc. 58 Jurilab 58 SYCREST 58 MicroDose 58 Tripep 58 Adeona Pharmaceuticals Inc. 58 TiGenix 58 Tracon Pharmaceuticals 58 CAMPATH 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 MitoKor 58 Trophos 58 RezularTM 58 AltaRex 58 NASDAQ RNAI 58 OMRIX Biopharmaceuticals Inc. 58 RhuDex 58 Enrolls First 58 Elan NanoCrystal 58 NTDDS 58 Bayer Yakuhin 58 Aureon 58 Draxis 58 Crit Rev 58 Nucryst Pharmaceuticals Corp. 58 Lexicon Genetics Incorporated 58 CorePharma 58 Exaeris 58 CDP# 58 cathepsin K inhibitor 58 Awarded Qualifying Therapeutic 58 novel peptides 58 AFFiRiS 58 NASDAQ BDSI 58 PHRM 58 Fentanyl Taifun 58 vapreotide acetate 58 Neosil 58 Panzem ® 58 Nanobody 58 Biovitrum AB 58 Deferiprone 58 Vitaflo Scandinavia AB 58 proprietary radiolabeled monoclonal 58 Gedeon Richter 58 Provectus Pharmaceuticals specializes 58 Eyetech Pharmaceuticals 58 UltiMAb 58 NASDAQ AKRX 58 Paramount BioSciences 58 Nasdaq ANPI 58 gefitinib Iressa 58 Cephalon NASDAQ CEPH 58 A5 Laboratories 58 Response Genetics 58 Biosyn 58 Proximagen 58 ABI OTCBB AMAR 58 Chipscreen 58 Nanobody R 58 Zeneus Pharma 58 intravenous AAT 58 Aganocide TM 58 Aerie Pharmaceuticals 58 Jörn Aldag President 58 Microbix Biosystems Inc. 58 IVMD 58 Antitope 58 epoetin zeta 58 CellMed 58 OTCBB IMUC 58 Affimed Therapeutics AG 58 Tyrian Diagnostics 58 Pierre Fabre Medicament 58 GlaxoSmithKline plc GSK 58 Diasome 58 Solstice Neurosciences 58 Azmacort 58 Inc. AMEX YMI 58 Campath ® 58 Victhom Human Bionics 58 Loramyc R 58 BioBalance Corporation 58 Cellgate Inc. 58 AC Immune 58 AtCor Medical 58 ASX PGL 58 Roche Trimeris 58 Kepivance 58 Rheoscience 58 NUCRYST Pharmaceuticals 58 Biotherapeutics 58 ENZON 58 PORxin TM 58 midstage clinical 58 adrenergic regulation 58 tiapamil 58 Roche SIX RO 58 Response Biomedical Corporation 58 Stragen 58 Arqule 58 acquire Molecular Devices 58 Resolvyx Pharmaceuticals 58 ImmunoVaccine Technologies Inc. 58 Novexel 58 Oral Calcitonin 58 Egalet 58 Guerbet 58 Preotact 58 OncoSec 58 TSX VENTURE CZO 58 Fukuda Denshi 58 Nanoemulsion 58 Ascent Therapeutics 58 Epiphany Biosciences 58 BioSepra 58 DiaKine 58 CoTherix Inc. 58 Inc. OTCBB SPRX 58 Amgen Bayer Schering 58 CeNeS Pharmaceuticals plc 58 Syrrx 58 IntelGenx Corp. 58 Stallergenes SA 58 PregLem 58 Fujirebio 58 TSX BSY 58 Abviva Inc. 58 Pennsaid ® 58 Skin Cholesterol Test 58 Nasdaq BSTE 58 EECP ® therapy 58 DiaPep# 58 SANOFI AVENTIS 58 Neuropharma 58 Arcxis Biotechnologies 58 DPX Survivac 58 Somatuline Depot 58 KL4 Surfactant 58 Alfa Wassermann 58 Cell Pathways 58 Achieves Primary Endpoint 58 immunodiagnostics 58 Supernus 58 Apricus Biosciences 58 Cerep 58 WHO TDR 58 Pepscan 58 GLASSIA 58 P#X# antagonist 58 Receives CE Marking 58 Stakeholder Opinions 58 Edimer Pharmaceuticals 58 RELOVAIR ™ 58 Omthera 58 PEGylated interferon 58 Nasdaq PGNX 58 Tacere 58 Announce Merger Agreement 58 Canderm Pharma 58 Botaneco Specialty Ingredients 58 Demonstrates Significant 58 EvoGenix 58 Nasdaq CRTX 58 MERREM 58 YM BioSciences Inc. 58 Belerofon 58 Paris IPN Euronext 58 Aldara ® 58 Teikoku Seiyaku 58 LEVADEX ™ 58 Announces FDA Clearance 58 OSI Eyetech 58 AltheaDx 58 Nobilon 58 Applied NeuroSolutions 58 Genelabs Technologies 58 Curagen 58 Submits Biologics License Application 58 Osmetech plc